← Browse by Condition
Medical Condition

recurrent fallopian tube high grade serous adenocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05920798 Phase 1, Phase 2
Recruiting

Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Enrollment
40 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →